Voya Investment Management LLC Decreases Stake in Revvity, Inc. (NYSE:RVTY)

Voya Investment Management LLC decreased its position in shares of Revvity, Inc. (NYSE:RVTY - Free Report) by 8.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 34,974 shares of the company's stock after selling 3,172 shares during the period. Voya Investment Management LLC's holdings in Revvity were worth $3,903,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of RVTY. Assetmark Inc. raised its position in shares of Revvity by 3,700.0% in the 4th quarter. Assetmark Inc. now owns 266 shares of the company's stock valued at $30,000 after purchasing an additional 259 shares during the last quarter. Millstone Evans Group LLC acquired a new position in Revvity during the 4th quarter valued at approximately $38,000. MassMutual Private Wealth & Trust FSB raised its holdings in shares of Revvity by 55.9% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 385 shares of the company's stock worth $43,000 after buying an additional 138 shares during the last quarter. EverSource Wealth Advisors LLC lifted its stake in shares of Revvity by 33.5% during the fourth quarter. EverSource Wealth Advisors LLC now owns 522 shares of the company's stock worth $58,000 after buying an additional 131 shares during the period. Finally, GeoWealth Management LLC purchased a new stake in shares of Revvity during the fourth quarter valued at $60,000. 86.65% of the stock is currently owned by institutional investors and hedge funds.

Revvity Price Performance

Revvity stock traded down $0.34 during trading on Wednesday, reaching $90.08. The company had a trading volume of 108,210 shares, compared to its average volume of 926,749. The company has a debt-to-equity ratio of 0.41, a quick ratio of 3.03 and a current ratio of 3.60. The firm's 50-day simple moving average is $101.95 and its 200 day simple moving average is $111.68. The firm has a market capitalization of $10.82 billion, a PE ratio of 40.71, a price-to-earnings-growth ratio of 3.82 and a beta of 1.02. Revvity, Inc. has a 1-year low of $88.53 and a 1-year high of $129.50.

Revvity (NYSE:RVTY - Get Free Report) last released its quarterly earnings results on Monday, April 28th. The company reported $1.01 earnings per share for the quarter, topping the consensus estimate of $0.96 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. The firm had revenue of $664.76 million during the quarter, compared to the consensus estimate of $662.30 million. During the same quarter in the prior year, the firm earned $0.98 EPS. The company's revenue for the quarter was up 2.3% on a year-over-year basis. As a group, equities research analysts anticipate that Revvity, Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, August 8th. Stockholders of record on Friday, July 18th will be paid a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.31%. The ex-dividend date is Friday, July 18th. Revvity's dividend payout ratio is presently 11.91%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on RVTY shares. JPMorgan Chase & Co. reduced their target price on Revvity from $120.00 to $100.00 and set a "neutral" rating for the company in a research note on Tuesday, April 29th. The Goldman Sachs Group decreased their target price on Revvity from $140.00 to $125.00 and set a "buy" rating for the company in a report on Tuesday, April 29th. UBS Group upgraded shares of Revvity from a "neutral" rating to a "buy" rating and cut their price target for the stock from $145.00 to $115.00 in a report on Thursday, May 1st. Raymond James restated an "outperform" rating and set a $120.00 price objective (down from $145.00) on shares of Revvity in a research note on Tuesday, April 29th. Finally, Sanford C. Bernstein lowered shares of Revvity from an "outperform" rating to a "market perform" rating and set a $130.00 price objective on the stock. in a research note on Friday, January 10th. Four equities research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $125.64.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.